CPN reported a net profit of Bt4.2b in 1Q25, up 2% yoy and 9% qoq, in line with our expectation. The rental and services segment continued to deliver resilient performance, while the residential business weighed on overall earnings growth during the quarter. We remain optimistic about the core business and maintain our earnings forecasts, with a growth of 5% in 2025. Maintain BUY. Target price: Bt79.60.
KEY HIGHLIGHTS Results Central Pattana (CPN TB/BUY/Bt50.50/Target: Bt79.60) 1Q25: Earnings in line, maintain earnings forecasts. Update Banpu (BANPU TB/HOLD/Bt4.38/Target: Bt4.80) Expect 1Q25 loss to narrow qoq. PTT (PTT TB/BUY/Bt32.25/Target: Bt37.00) Subsidiary and affiliate recovery drives 1Q25 net profit higher qoq.
GREATER CHINA Strategy China And Hong Kong Property Market watch around May holiday: New-home sales recovery weakens in Apr 25; the trend of Hong Kong resident travelling north remains strong. Sector Consumer Strong Macau visitations and robust home appliance sales during Labour Day Holiday. INDONESIA Initiate Coverage Aneka Tambang (ANTM IJ/BUY/Rp2,540/Target:...
GREATER CHINA Strategy Alpha Picks: May Conviction Calls: Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. INDONESIA Strategy Alpha Picks: Outperformance In Apr 25: Remove ICBP, EXCL and MIKA; add BBTN and GOTO. MALAYSIA Strategy Alpha Picks: Capitalising On Sentiment Turnaround: Our Apr 25 Alpha Picks underperformed. May 25 picks: Duopharma, Gamuda, IJM, IOI Properties, TIME dotCom, MYEG, Nationgate, Northeast Group and RHB Bank. SINGAPO...
GREATER CHINA Strategy Alpha Picks: May Conviction Calls Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. Sector Aviation Airlines: 1Q25 results below expectations. Weak fuel prices to support full-year performance. Maintain UNDERWEIGHT. INDONESIA Strategy 1Q25 Results Recap ...
CPN is expected to report a net profit of Bt4.2b in 1Q25 (flat yoy, +7% qoq). We anticipate continued resilience in the rental and services business, while the residential segment is likely to see a sharp fall in transfers during 1Q25. We maintain our earnings forecast, projecting a new record high in 2025. Maintain BUY. Target price: Bt79.60.
KEY HIGHLIGHTS Update Bangkok Dusit Medical Services (BDMS TB/BUY/Bt23.50/Target: Bt33.00) Expect a healthy growth in 1Q25. Central Pattana (CPN TB/BUY/Bt48.50/Target: Bt79.60) Expect 1Q25 earnings to be stable yoy; resilient core business performance. PTT Global Chemical (PTTGC TB/BUY/Bt18.20/Target: Bt21.00) 1Q25 loss projected to decline qoq.
GREATER CHINA Initiate Coverage Tencent Music Entertainment Group (1698 HK/BUY/HK$47.80/Target: HK$60.00) World’s largest music platform with evolving social ecosystem. Results Dian Diagnostics (300244 CH/HOLD/Rmb13.99/Target: Rmb15.00) 2024: Results in line; maintain 2025 revenue growth estimate of 8.8% yoy. iFlytek (002230 CH/SELL/Rmb45.18/Target: Rmb35.00) 2024 and 1Q25: Earnings miss on heightened R&D spending; solid top-line growth. Update Sunn...
GREATER CHINA Strategy Alpha Picks: April Conviction Calls: Add CR Beer, Desay, JBM Healthcare, JD Logistics, Minth, WuXi App Tech and Xiaomi Corp to our BUY list. Take profit on AIA, Hansoh Pharma, JD and Zijin Mining. INDONESIA Strategy Alpha Picks: Outperform In Mar 25: Remove BBNI, BBRI, ASII, JSMR and KLBF; add BBCA, ICBP, ERAA and BUKA. MALAYSIA Strategy Alpha Picks: Pockets of Opportunities: Our Mar 25 Alpha Picks outperform. Apr 25 picks: Alpha IVF, Duopharma, IJM, IOI Properties, TIME...
CPN’s revenue growth is expected to slow in 2025, with modest gains across the rental and hotel segments. However, we remain optimistic about its earnings outlook, supported by a Bt120b investment plan focused on retail, mixed-use expansion, and asset renovations. Maintain BUY. Target price: Bt79.60.
GREATER CHINA Results COSCO SHIPPING Ports (1199 HK/BUY/HK$4.78/Target: HK$5.90) 2024: Core earnings in line; expect low single digit throughput growth in 2025. CSPC Innovation Pharmaceutical Co (300765 CH/BUY/Rmb37.00/Target: Rmb50.00) 2024: Smooth progress in R&D promises bright long-term outlook. Hansoh Pharmaceutical Group Company (3692 HK/BUY/HK$20.10/Target:HK$29.00) 2024: Results beat; strong growth momentum continues. Meituan (3690 HK/BUY/HK$167.60/Target: HK$216.00) ...
A director at Central Pattana Plc bought 230,000 shares at 50.446THB and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
GREATER CHINA Strategy Alpha Picks: March Conviction Calls: Add Geely, JD, SHKP and Zijin Mining to our BUY list. Take profit on CATL, Desay, JD Logistics, Mengniu, Plover Bay and Tencent. INDONESIA Strategy Alpha Picks: Underperformance In Feb 25: Our picks are BBNI, BBRI, MIKA, EXCL, KLBF, JSMR and ASII. MALAYSIA Strategy Alpha Picks: Unprecedented Combo Of Disappointments: Our Feb 25 Alpha Picks sorely underperformed. Mar 25 picks: 99SpeedMart, Alpha IVF, KPJ Healthcare, MrDIY, MYEG, RHB Ba...
CPN posted a net profit of Bt3.89b in 4Q24 (-2% yoy, -6% qoq), 9% above estimates due to lower-than-expected SG&A expenses. Core profit rose 11% yoy and 7% qoq to Bt4.2b, driving record-high 2024 earnings. CPN announced a record dividend with a 4.3% yield. While challenges persist in the residential segment, the rental business remains resilient. 2025 earnings growth may be modest, but solid fundamentals and strategic expansion support long-term growth. Maintain BUY. Target price: Bt79.30.
KEY HIGHLIGHTS Results Bangkok Chain Hospital (BCH TB/BUY/Bt15.70/Target: Bt20.00) 4Q24: Weaker-than-expected earnings. Central Pattana (CPN TB/BUY/Bt49.25/Target: Bt79.30) 4Q24: Earnings exceeded estimates; record dividend announced. Electricity Generating PCL (EGCO TB/BUY/Bt96.25/Target: Bt120.00) 4Q24: Results in line with good outlook. Update LPN Development (LPN TB/SELL/Bt2.18/Target: Bt1.60) Unexciting business plan for...
GREATER CHINA Economics PMI: Uptick in February. Sector Macau Gaming: Feb 25 GGR beat thanks to tail-end effect post CNY; switch top pick to Galaxy. Results New World Development (17 HK/HOLD/HK$4.82/Target: HK$4.45): 1HFY25: Net loss in line with profit warning and primarily caused by inventory impairment; refinancing progress to be the key. Xinyi Solar Holdings (968 HK/HOLD/HK$3.29/Target: HK$3.60): 2024: Below expectations; industry coordination and production discipline crucial to restore mar...
CPN is expected to report a net profit of Bt3.6b in 4Q24 (-10% yoy, -13% qoq). The earnings are likely to be pressured by high seasonal SG&A expenses. However, full-year earnings are projected to hit a new record high in 2024. We continue to view CPN as a long-term investment. Maintain BUY. Target price: Bt79.30.
KEY HIGHLIGHTS Update Bumrungrad Hospital (BH TB/BUY/Bt175.50/Target: Bt232.00) Weak 4Q24 earnings expected. Central Plaza Hotel (CENTEL TB/BUY/Bt28.00/Target: Bt33.00) Reaching a turning point; upgrade to BUY. Central Pattana (CPN TB/BUY/Bt52.25/Target: Bt79.30) Expect 4Q24 earnings to be pressured by SG&A, but 2024 is set to deliver a record profit.
GREATER CHINA Sector Automobile Weekly: PV sales stay low, BYD to equip all EVs with DiPilot ADAS. Upgrade BYD to BUY. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely, CATL, Fuyao and Desay. Update AAC Technologies (2018 HK/HOLD/HK$46.55/ Target: HK$48.00) 2024 profit alert – earnings set to beat expectations. Maintain HOLD. The United Laboratories International (3933 HK/HOLD/HK$12.42/Target: H...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.